According to China Drug Distribution Industry Report, 2012-2015 released by Sino Market Insight, the total sales of Chinese drug distribution industry is estimated to surge 102% over 2011 to RMB1.4288 trillion in 2015.
In 2011, the sales of Chinese drug distribution industry totalized RMB942.6 billion, attaining a YoY rise of 23% if excluding non-comparable factors. In 2012, the figure will grow10% YoY to RMB1.0367 trillion. It is expected that the figure will hit RMB1.4288 trillion in 2015, and that Chinese drug retailing industry (including non-medicines) will sustain a CAGR of 11% or so in 2013-2015.
In the forthcoming years, drug distribution in China will characterize the followings:
The industry growth will accelerate in rural market. Among the sales of seven major types of pharmaceuticals in 2011, the sales derived from rural areas climbed 27% over the same period of a year earlier (excluding non-comparable factors) to RMB146.1 billion, with the growth rate rising by roughly 4 percentage points. With the development of rural economy and residents’ concern about their own health, the pharmaceutical sale in rural areas is likely to contribute a larger proportion to the total sales.
The concentration degree of drug retail industry will be further enhanced. Of all the sales of top 100 retail chain companies in 2011, the sales of the top 20 enterprises made up 61%, up 3 percentage points. The drug distribution industry tends to be integrated in the future.
The report covers seven chapters and 118 charts, and highlights the market size and competitive landscape of drug distribution industry in China, market status of wholesale and retail market, as well as financial performance, business development and trends of 10 major drug distribution companies.
1. Overview of Chinese Drug Distribution Industry
1.1 Definition
1.2 Industry Chain
1.3 Profit Model
1.4 International Drug Distribution Industry
1.4.1 USA
1.4.2 Japan
1.4.3 Drug Distribution Industry in China, USA, Japan and Europe
1.5 Operation Characteristics
2. Development Environment for Chinese Drug Distribution Industry
2.1 Policy Environment
2.2 China’s Macroeconomic Environment in 2011-H1 2012
2.2.1 China’s GDP
2.2.2 Per Capita Disposable Income of Urban and Rural Households
2.2.3 Engle Coefficient
2.2.4 Industrial Development
2.2.5 Import and Export
2.3 Forecast of China’s Main Macroeconomic Indicators in 2012-2013
3. Market Size and Forecast of Chinese Drug Distribution Industry
3.1 Overall Size
3.2 Sales Structure
3.3 Ownership Structure
3.4 Distribution Structure
3.5 Competitive Landscape
3.5.1 Competition Pattern of Drug Distribution Industry
3.5.2 Comparative Analysis of Top 30 Enterprises in 2011
3.6 Investment and Financing
4. Chinese Drug Distribution Industry Segments
4.1 Wholesale Industry
4.2 Retail Industry
4.2.1 Intensiveness Trend Progresses Slowly
4.2.2 Policies Bring about Opportunities and Challenges
4.2.3 Five Directions during Sub-high Growth Period
5. Chinese Drug Distribution Industry by Region
5.1 Overview
5.2 Shanghai
5.3 Beijing
5.4 Anhui Province
5.5 Zhejiang Province
5.6 Jiangsu Province
5.7 Shandong Province
5.8 Guangdong Province
5.9 Chongqing
5.10 Tianjin
5.11 Hubei Province
5.12 Other Regions
6. Operation of Pharmaceutical Logistics Companies
6.1 Shanghai Pharmaceuticals Holding Co., Ltd.
6.1.1 Profile
6.1.2 Operation
6.1.3 Business Development
6.1.4 Revenue and Profit of Main Subsidiaries
6.2 Jointown Pharmaceutical Group Co., Ltd. (600998)
6.2.1 Profile
6.2.2 Operation
6.2.3 Business Development
6.3 Nanjing Pharmaceutical Co., Ltd.
6.3.1 Profile
6.3.2 Operation
6.3.3 Business Development
6.4 Huadong Medicine Co., Ltd. (000963)
6.4.1 Profile
6.4.2 Operation
6.4.3 Business Development
6.5 Harbin Pharmaceutical Group Co., Ltd. (600664)
6.5.1 Profile
6.5.2 Operation
6.5.3 Business Development
6.6 China Meheco Co., Ltd. (600056)
6.6.1 Profile
6.6.2 Operation
6.6.3 Business Development
6.7 Sinopharm Group Co., Ltd. (01099.HK)
6.7.1 Profile
6.7.2 Operation
6.7.3 Business Development
6.8 China Nepstar Chain Drugstore Ltd. (NYSE: NPD)
6.8.1 Profile
6.8.2 Operation
6.9 Shanghai No. 1 Pharmacy Co., Ltd. (600833)
6.9.1 Profile
6.9.2 Operation
6.9.3 Business Development
6.10 Beijing Tongrentang Co., Ltd. (600085)
6.10.1 Profile
6.10.2 Operation
6.10.3 Business Development
7. Development Trend of Drug Distribution Industry
7.1 Status Quo
7.2 Development Trend
7.2.1 Market Size will Continue to Expand
7.2.2 Adjustment of Industrial Structure Will Quicken
7.2.3 Industry Service Model and Function Will be Further Upgraded
List of Figures
Drug Distribution Industry Chain
Emerging Profit Model of Chinese Drug Distribution Industry
Drug Distribution Industry Chain in the U.S.
Market Concentration of Drug Distribution Industry in the U.S., 1990-2010
Drug Distribution Industry Chain in Japan
Market Concentration of Drug Distribution Industry in Japan, 1999-2010
Market Concentration of Drug Distribution Industry in China, the U.S., Japan and Europe, 2010
Policies Concerning Logistics Industry Promulgated in China, as from 2001
YoY Growth Rate of China’s GDP, 2001-2012
Per Capita Disposable Income of Urban Households in China, 1985-2011
Engel Coefficient of Urban and Rural Households in China
YoY Growth Rate of Added Value of Industrial Enterprises above Designated Size, 2000-2012
YoY Growth Rate of Export Delivery Value in China, 2008-2012
Total Import and Export Value and Growth Trend in China, 2001-2012
Import and Export Growth and Balance in China, 2001-2012
Total Import and Export Value by Country (Region), Jul. 2012
Export Volume and Value of Major Export Commodities in China, Jan.-Jul. 2012
Import Volume and Value of Major Import Commodities in China, Jan.-Jul. 2012
Export Structure of Medicines and Healthcare Products in Beijing, Jan.-Jun. 2012
Export Structure of Medicines and Healthcare Products in Shanghai, Jan.-Jun. 2012
Export Structure of Medicines and Healthcare Products in Tianjin, Jan.-Jun. 2012
Forecast of Main Macroeconomic Indicators in China, 2012-2013E
Total Sales of Pharmaceuticals, 2007-2015E
Main Economic Indicators of Drug Distribution Enterprises, 2011
Accounts Receivable of Drug Wholesale Enterprises, 2011
Operating Revenue Structure of Drug Distribution Enterprises (above Designated Size) by Ownership, 2011
Total Profit Structure of Drug Distribution Enterprises (above Designated Size) by Ownership, 2011
Merchandise Distribution Struture of Pharmaceutical Wholesale Enterprises, 2011
Logistics Cost Structure of Drug Wholesale Enterprises, 2011
Market Share of Drug Distribution and Major Distribution Enterprises in Major Regions in China, 2011
Market Structure of Three Formats of Chinese Drug Distribution Industry, 2012
Competitive Landscape of Drug Distribution Market in Beijing, 2011-2015E
Competitive Landscape of Drug Distribution Market in Shanghai, 2011-2015E
Competitive Landscape of Drug Distribution Market in Guangdong, 2011-2015E
Distribution Structure of Key Drug Wholesale Enterprises by Sales Channel, 2012
Top 30 Wholesale Enterprises by Operating Revenue, 2011
Top 30 Retail Enterprises by Total Sales, 2011
PE / VC of Health Care Product Distributors Industry in China, 2011-2012
PE / VC of Health Care Product Distributors Industry in China, 2012
Market Size of Drug Wholesale Industry in China, 2010-2015E
Revenue of Drug Wholesale Enterprises in China by Type, 2011-2015E
Market Size of Drug Retail Industry in China, 2010-2015E
Market Size of Drug Retail Industry in China by Type, 2010-2015E
Drug Sales in China by Type, 2007-2015E
Drug Sales in Shanghai by Type, 2010-2015E
Drug Sales in Beijing by Type, 2010-2015E
Drug Sales in Anhui by Type, 2010-2015E
Drug Sales in Zhejiang by Type, 2010-2015E
Drug Sales in Jiangsu by Type, 2010-2015E
Drug Sales in Shandong by Type, 2010-2015E
Drug Sales in Guangdong by Type, 2010-2015E
Drug Sales in Chongqing by Type, 2010-2015E
Drug Sales in Tianjin by Type, 2010-2015E
Drug Sales in Hubei by Type, 2010-2015E
Total Drug Sales in China by Region, 2011-2015E
Drug Sales in China by Region, 2010-2015E
Sales of Chinese Patent Drug in China by Region, 2010-2015E
Sales of Traditional Chinese Medicine in China by Region, 2011-2015E
Sales of Medical Equipment in China by Region, 2010-2015E
Key Indicators of Shanghai Pharmaceuticals Holding Co., Ltd, 2011-2012
Income Statement Abstract of Shanghai Pharmaceuticals Holding Co., Ltd, 2011-2012
Balance Sheet Abstract of Shanghai Pharmaceuticals Holding Co., Ltd, 2011-2012
Cash Flow Statement Abstract of Shanghai Pharmaceuticals Holding Co., Ltd, 2011-2012
Revenue and Gross Margin of Shanghai Pharmaceuticals Holding Co., Ltd by Product, 2010-2012
Revenue and Gross Margin of Shanghai Pharmaceuticals Holding Co., Ltd by Region, 2010-2012
Revenue and Profit of Major Subsidiaries of Shanghai Pharmaceuticals Holding Co., Ltd.
Key Indicators of Jointown Pharmaceutical Group Co., Ltd., 2011-2012
Income Statement Abstract of Jointown Pharmaceutical Group Co., Ltd., 2011-2012
Balance Sheet Abstract of Jointown Pharmaceutical Group Co., Ltd., 2011-2012
Cash Flow Statement Abstract of Jointown Pharmaceutical Group Co., Ltd., 2011-2012
Revenue and Gross Margin of Jointown Pharmaceutical Group Co., Ltd. by Product, 2010-2012
Revenue of Jointown Pharmaceutical Group Co., Ltd. by Region, 2010-2012
Key Indicators of Nanjing Pharmaceutical Company Limited, 2011-2012
Income Statement Abstract of Nanjing Pharmaceutical Company Limited, 2011-2012
Balance Sheet Abstract of Nanjing Pharmaceutical Company Limited, 2011-2012
Cash Flow Statement Abstract of Nanjing Pharmaceutical Company Limited, 2011-2012
Revenue and Gross Margin of Nanjing Pharmaceutical Company Limited by Product, 2010-2012
Revenue of Nanjing Pharmaceutical Company Limited by Region, 2010-2012
Key Indicators of Huadong Medicine Co., Ltd., 2011-2012
Income Statement Abstract of Huadong Medicine Co., Ltd., 2011-2012
Balance Sheet Abstract of Huadong Medicine Co., Ltd., 2011-2012
Cash Flow Statement Abstract of Huadong Medicine Co., Ltd., 2011-2012
Revenue and Gross Margin of Huadong Medicine Co., Ltd. by Product, 2010-2012
Revenue and Gross Margin of Huadong Medicine Co., Ltd. by Region, 2010-2012
Key Indicators of Harbin Pharmaceutical Group Co., Ltd., 2011-2012
Income Statement Abstract of Harbin Pharmaceutical Group Co., Ltd., 2011-2012
Balance Sheet Abstract of Harbin Pharmaceutical Group Co., Ltd., 2011-2012
Cash Flow Statement Abstract of Harbin Pharmaceutical Group Co., Ltd., 2011-2012
Revenue and Gross Margin of Harbin Pharmaceutical Group Co., Ltd. by Product, 2011-2012
Revenue and Gross Margin of Harbin Pharmaceutical Group Co., Ltd. by Region, 2011-2012
Key Indicators of China Meheco Co., Ltd., 2011-2012
Income Statement Abstract of China Meheco Co., Ltd., 2011-2012
Balance Sheet Abstract of China Meheco Co., Ltd., 2011-2012
Cash Flow Statement Abstract of China Meheco Co., Ltd., 2011-2012
Revenue and Gross Margin of China Meheco Co., Ltd. by Product, 2011-2012
Key Indicators of Sinopharm Group Co., Ltd., 2011-2012
Balance Sheet Abstract of Sinopharm Group Co., Ltd., 2011-2012
Income Data of China Nepstar，2007-2011
Consolidated Balance Sheet Data of China Nepstar，2007-2011
Key Indicators of Shanghai No.1 Pharmacy Co., Ltd., 2011-2012
Income Statement Abstract of Shanghai No.1 Pharmacy Co., Ltd., 2011-2012
Balance Sheet Abstract of Shanghai No.1 Pharmacy Co., Ltd., 2011-2012
Cash Flow Statement Abstract of Shanghai No.1 Pharmacy Co., Ltd., 2011-2012
Revenue and Gross Margin of Shanghai No.1 Pharmacy Co., Ltd. by Product, 2011-2012
Revenue and Gross Margin of Shanghai No.1 Pharmacy Co., Ltd. by Region, 2011-2012
Key Indicators of Beijing Tongrentang Co., Ltd, 2011-2012
Income Statement Abstract of Beijing Tongrentang Co., Ltd, 2011-2012
Balance Sheet Abstract of Beijing Tongrentang Co., Ltd, 2011-2012
Cash Flow Statement Abstract of Beijing Tongrentang Co., Ltd, 2011-2012
Revenue and Gross Margin of Beijing Tongrentang Co., Ltd by Region, 2011-2012
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : November 2019
$ 3600
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
